View Archive

Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca, Clovis Oncology, Myriad Genetics Laboratories, and Tesaro Inc.

Not an official event of the 2018 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO, CancerLinQ, or the Conquer Cancer Foundation.

ASCO: Medical Crossfire®: Evolving Applications for PARP Inhibitors in Ovarian Cancer: Building on a Solid Foundation

ASCO: Medical Crossfire®: Evolving Applications for PARP Inhibitors in Ovarian Cancer: Building on a Solid Foundation

Sunday, June 3, 2018
Time: 7:00 PM – 9:00 PM
Dinner and registration: 6:30 PM – 7:00 PM

Hilton Chicago
International Ballroom North (Second Level)
720 S. Michigan Avenue
Chicago, IL 60605

What You'll Learn

  • The utility of PARP inhibition in ovarian cancer
  • How to improve patient outcomes with data from Chicago
  • Adverse event management PARP inhibitor treatment


Multiple poly (ADP-ribose) polymerase (PARP) inhibitors have been approved for both treatment and ongoing maintenance indications following the results of recent key studies. These approvals have heralded an opportunity to significantly improve outcomes for your patients. It can be difficult for any clinician to keep up with the accelerated pace and volume of clinical advancements associated with PARP inhibition, and we would like to present an opportunity to help you stay current and arm yourselves with the clinical knowledge and insight necessary to optimize safety and efficacy outcomes for your patients.

We have developed an educational activity that will feature a panel of experts in the management of ovarian cancer who will present and assess the latest data on PARP inhibition and the clinical implications of the data for your practice. The Medical Crossfire® format for this symposium is ideally suited for you to consider expert perspectives on key learning points pertaining to the use of PARP inhibition in ovarian cancer. During this case-based activity, clinical scenarios will be presented that explore nuances of patient care that may enhance your own practice. Decisions that are made in real-world clinical scenarios are not always clearly demarcated by clinical trial data, and this activity will give you the chance to hear how the experts substantiate their decision making when multiple treatment options may be viable.

Program Chair:

Robert L. Coleman, MD, FACOG, FACS
Professor & Executive Director, Cancer Network Research
Ann Rife Cox Chair in Gynecology
Department of Gynecologic Oncology and Reproductive Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

This activity is supported by educational grants from AstraZeneca, Clovis Oncology, Myriad Genetics Laboratories, and Tesaro Inc.


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

Please note that attendance is on a first-come, first-served basis. Please arrive early to ensure your spot!

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.    

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.

Click to see all our ASCO programs!

Calendar of Events
Filter By